Evidence map›Paper›PMID 34123797›Full record

ArticleFrontiers in oncology2021

Construction and Identification of New Molecular Markers of Triple-Negative Breast Cancer Stem Cells.

Tingting Liu, Hongyue Wang, Zhiyong Liu, Jing Zhang, Yan Liu, Lin Zhang, Chunhui Zheng, Fei Liu, Chuanqiang Hou, Baojiang Li

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 49% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Tingting LiuDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Hongyue WangDepartment of Central Sterile Supply, Tai'an Central Hospital, Tai'an, China.
Zhiyong LiuDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Jing ZhangDepartment of Ultrasonic Diagnosis, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Yan LiuDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Lin ZhangDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Chunhui ZhengDepartment of Oncology Surgery, Weifang People's Hospital, Weifang, China.
Fei LiuDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Chuanqiang HouDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Baojiang LiDepartment of Breast Surgery, Breast Cancer Center, Tai'an Central Hospital, Tai'an, China.
Taian City Central Hospital · CNWeifang People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

cancer stem cellidentificationmarkerphagetriple-negative breast cancer

Identifiers

PMID34123797
PMCPMC8193032
OpenAlexW3168447741

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.